Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11
November 04, 2023 12:00 ET
|
Medigene AG
Planegg/Martinsried, November 4, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Global Immunology Market Soars with Projected $56.07 Billion Growth by 2027, Fueled by Surging Cases of Infectious Diseases
November 02, 2023 06:23 ET
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Immunology Market 2023-2027" report has been added to ResearchAndMarkets.com's offering. The immunology market is poised for remarkable...
Homeopathy Market Worth Nearly $18 Billion by 2030- Exclusive Report by The Insight Partners
October 27, 2023 08:19 ET
|
The Insight Partners
Pune, India, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Homeopathy is an alternative form of medicine that uses highly diluted substances to stimulate the body’s natural healing abilities. Several factors...
Medigene Reports Financial Results and Corporate Update for Q3 2023
October 26, 2023 02:30 ET
|
Medigene AG
Focus on executing the strategic plan and delivering shareholder valueFirst MDG2011 pre-clinical data support potential in solid tumor therapyExpansion of patent portfolio and license agreement for...
Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with a PD1-41BB costimulatory switch protein showing enhanced and sustained tumor killing
October 23, 2023 03:00 ET
|
Medigene AG
Planegg/Martinsried, October 23, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard) an immuno-oncology platform company focusing on the discovery and development of T cell...
Correction: ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
October 18, 2023 15:50 ET
|
ImCheck Therapeutics SAS
ImCheck to Present New Positive Data on ICT01 Monotherapyin Hematological Cancers at ESMO 2023 Interim data from Phase I dose escalation portion of EVICTION Phase I/IIa trialshow strong safety...
Medigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023
October 16, 2023 08:00 ET
|
Medigene AG
Planegg/Martinsried, October 16, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
October 15, 2023 18:05 ET
|
ImCheck Therapeutics SAS
ImCheck to Present New Positive Data on ICT01 Monotherapyin Hematological Cancers at ESMO 2023 Interim data from Phase I dose escalation portion of EVICTION Phase I/IIa trialshow strong safety...
Explosive Growth in Dietary Supplements Underscores Relevance of New China E-commerce Market Data Report for Entrepreneurs
October 10, 2023 09:48 ET
|
Research and Markets
Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) -- In a time where health consciousness has never been more prevalent, the numbers say it all. According to the Institute of Medicine and National Research...
Single-Cell Omics Market revenue to hit USD 30 Billion by 2035, says Research Nester
October 03, 2023 06:09 ET
|
Research Nester
New York, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The global single-cell omics market size is expected to expand at ~22% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 30...